- Business Type:
- Manufacturer
- Year Established:
- 2003
- Total Revenue:
- Main Markets:
- North America, Eastern Europe, Southeast Asia, Oceania, Mid East, Western Europe
Company Description
BEIJING Zhongshuo focus on the R&D, manufacture and exporting of APIs (Emphasize particularly on Oncology, Nucleotide, Immunology, Cardiovascular, Neurology etc) and associated pharmaceutical intermediates.
Our mainly product:
Entecavir, Rocuronium Bromide, Adefovir Dipivoxil, Paclitaxel, Docetaxel, Tenofovir, Reboxetine Mesylate, Doxorubicin, Doripenem,Emtritabine, Fulvestrant, Meropenem, 5-Fluorouraci, Natural Colors, Natual Nutrition Extract and so on. (For more detailed information such as Product list if you need, welcome to visit our website.